ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma

Background: Although ALYREF has been demonstrated to have a role in a number of malignancies, its role in hepatocellular carcinoma (HCC) has received little attention. Our objective was to research at the prognostic value, biological role and relevance of ALYREF to the immune system in HCC. Methods:...

Full description

Bibliographic Details
Main Authors: Han, A.-Q (Author), Liu, Y. (Author), Meng, T. (Author), Qian, B. (Author), Wang, H.-X (Author), Wang, W. (Author), Wang, Z.-Z (Author), Wu, J. (Author), Yang, M.-Y (Author), Zhang, Y. (Author), Zhu, L.-X (Author)
Format: Article
Language:English
Published: Neoplasia Press, Inc. 2022
Subjects:
ALYREF
HCC
Immune
Nomogram
Prognosis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items